Aastrom Biosciences, Inc. (ASTM) Posts Q3 Loss of 6c/Share

November 12, 2013 4:08 PM EST Send to a Friend
Aastrom Biosciences, Inc. (NASDAQ: ASTM) reported Q3 EPS of ($0.06), $1.96 better than the analyst estimate of ($2.02).

The substantial decrease in net loss from the prior year is primarily due to decreases in research and development and general and administrative expenses and the non-cash change in the fair value of warrants.

For earnings history and earnings-related data on Aastrom Biosciences, Inc. (ASTM) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment